🇺🇸 FDA

Intelligence Platform

Patents

Browse 56 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11191849

Compositions and methods for delivering messenger RNA

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11141378

Lipid formulations for nucleic acid delivery

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Oct 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11130740

Substituted 2,3-dihydro-1H-indene analogs and methods using same

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11098010

Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11077197

Lipids and compositions for the delivery of therapeutics

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11013726

Substituted pyridinone-containing trycyclic compounds, and methods using same

ARBUTUS BIOPHARMA CORPORATION · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11001564

Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same

ARBUTUS BIOPHARMA CORPORATION · Granted Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10953095

Lipid compositions

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10835612

Lipids and compositions for the delivery of therapeutics

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10821186

Lipids and compositions for the delivery of therapeutics

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10821103

Substituted pyridinone-containing trycyclic compounds, and methods using same

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10653780

Amino lipids and methods for the delivery of nucleic acids

ARBUTUS BIOPHARMA CORPORATION · Granted Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10626393

Delivering CRISPR therapeutics with lipid nanoparticles

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10561732

Trialkyl cationic lipids and methods of use thereof

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10550084

Substituted 1-hydroxy-pyridin-2(1H)-ones, and methods of making and using same

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10456473

Lipid compositions

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10415037

Compositions and methods for silencing hepatitis B virus gene expression

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10358447

Substituted 2-N-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, and methods of making

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10117941

Lipids and compositions for the delivery of therapeutics

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10077232

Cyclic cationic lipids and methods of use

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10053689

Methods for increasing efficacy of lipid formulated siRNA

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9938236

Antiviral agents against HBV infection

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9895448

Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9814777

Targeting lipids

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted